Herpesvirus reactivation during severe COVID-19 and high rate of immune defect

OBJECTIVE: We assessed herpesvirus reactivation in severe SARS-CoV-2 infection. METHODS: Retrospective study including consecutive patients admitted to an onco-hematology intensive care unit (ICU) for severe COVID-19. Replication of EBV, CMV, and HSV was evaluated. Competing risk analyses were used...

Descripción completa

Detalles Bibliográficos
Autores principales: Saade, A., Moratelli, G., Azoulay, E., Darmon, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317452/
https://www.ncbi.nlm.nih.gov/pubmed/34332165
http://dx.doi.org/10.1016/j.idnow.2021.07.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317452/
https://www.ncbi.nlm.nih.gov/pubmed/34332165
http://dx.doi.org/10.1016/j.idnow.2021.07.005

Ejemplares similares